Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Patenting human genes].

R Brdicka1

  • 1Ustav hematologie a krevní transfuze, Akreditovaná Národní referencní laborator pro DNA diagnostiku, Praha. molgen@uhkt.cz

Casopis Lekaru Ceskych
|June 14, 2002
PubMed
Summary
This summary is machine-generated.

Patenting human genes, particularly for breast cancer genetic testing, is a complex issue. While companies invest in discoveries, gene patents may limit public access to crucial genetic tests, highlighting legal ambiguities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncolytic viruses and cancer treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2023
Same author

[The substance of genetic information--nucleic acids].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2012
Same author

Transcriptome alterations in maternal and fetal cells induced by tobacco smoke.

Placenta·2011
Same author

HVRII of mtDNA in cord blood cells of newborn children and in their saliva 10 years later.

Folia biologica·2011
Same author

[Personalized medicine--genomic phase].

Casopis lekaru ceskych·2010
Same author

Effect of maternal tobacco smoke exposure on the placental transcriptome.

Placenta·2010
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Area of Science:

  • Biotechnology Law
  • Genetic Diagnostics
  • Intellectual Property Rights

Context:

  • The patenting of human genes is a contentious issue, particularly concerning genetic predisposition tests for diseases like breast cancer.
  • Discussions at the Organisation for Economic Co-operation and Development (OECD) workshop underscore the growing relevance of this topic.
  • Granted patents on genetic diagnostic methods raise concerns about accessibility and commercial interests.

Purpose:

  • To examine the implications of patenting human genes on the accessibility of genetic testing.
  • To analyze the legal landscape surrounding gene patenting, including existing European Council directives.
  • To highlight the conflict between commercial investment in genetic research and public health access.

Summary:

Related Experiment Videos

  • Patents granted for human genes, especially those related to breast cancer genetic testing, present a significant challenge.
  • Companies argue for patent protection due to substantial research investments.
  • However, these patents can restrict the widespread availability and affordability of essential genetic diagnostic services.

    • Impact:

    • Gene patenting can create barriers to accessing genetic testing, potentially impacting patient care and disease management.
    • The ambiguity in current legal frameworks, such as the European Council Directive, necessitates clearer regulations.
    • Resolving these patenting issues is crucial for balancing innovation in genetic research with equitable access to diagnostic technologies.